BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14575013)

  • 1. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys.
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Surowiec S; Wolfshaut R; Loster M; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):970-7. PubMed ID: 19784901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention of ischemic heart disease in diabetics in clinical practice].
    Pajak A; Jankowski P; Wolfshaut R; Kawecka-Jaszcz K
    Pol Arch Med Wewn; 2004 Oct; 112(4):1189-96. PubMed ID: 15773431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2001; 58(11):953-5. PubMed ID: 11987834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice.
    Starkey C; Michaelis J; de Lusignan S
    Public Health; 2000 May; 114(3):169-75. PubMed ID: 10878743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention in chronic coronary heart disease].
    Hunziker P; Bertel O
    Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention in patients before and after percutaneous transluminal coronary angioplasty: 5-year follow-up].
    Muntwyler J; Maschio Andrist M; Amann FW
    Schweiz Med Wochenschr; 1997 Apr; 127(14):573-8. PubMed ID: 9198883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
    Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
    Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.